Search
for
Sort by
Research 211–240 of 219
- Sex-Chromosome-Related Dimorphism in Steroidogenic Enzymes and Androgen Receptor in Response to Testosterone Treatment: An In Vitro Study on Human Primary Skeletal Muscle Cells
- Study of Drug Target Identification and Associated Molecular Mechanisms for the Therapeutic Activity and Hair Follicle Induction of Two Ashwagandha Extracts Having Differential Withanolide Constitutions
- Blank Spots in the Map of Human Skin: The Challenge for Xenotransplantation
- Female Pattern Hair Loss: An Overview with Focus on the Genetics
- Testosterone: The Male Sex Hormone
- Forensic DNA Phenotyping
- A case report and literature review of delayed telogen effluvium after topical imiquimod use in treating a cervical high-grade squamous intraepithelial lesion
- Ectopic olfactory receptors in human: New therapeutic possibilities
- Enzymes
- Proceedings of the Heinz Maurer-Symposium “Review and Preview in Science for Healthy Skin” June 28th 2014, Jakobsberg, Boppard, Germany
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Role of janus kinase inhibitors in the treatment of alopecia areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- A review of Janus kinase inhibitor use in scarring alopecia
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- BH14 Irish dermatologists’ experience with Janus kinase inhibitors in alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Aim to alleviate alopecia areata with newly available agents
- Ceramide Synthase 4 Regulates Stem Cell Homeostasis and Hair Follicle Cycling
- Rupert Raj’s Written Acts of Activism and Care Throughout the 1980s and 1990s